Related Experiment Videos
Glucagon-like peptide-2: divergent signaling pathways.
Flavio G Rocha1, K Robert Shen, Jasleen Jasleen
1Department of Surgery, Brigham & Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, USA.
The Journal of Surgical Research
|August 18, 2004
Summary
Glucagon-like peptide 2 (GLP-2) directly promotes intestinal epithelial cell proliferation. This effect is mediated by a G-protein signaling pathway involving cyclic AMP (cAMP).
Area of Science:
- Gastroenterology
- Cell Biology
- Molecular Biology
Background:
- Glucagon-like peptide 2 (GLP-2) is an endogenous hormone.
- GLP-2 exhibits significant intestinotrophic activity in vitro and in vivo.
- Understanding GLP-2's signal transduction is crucial for its therapeutic potential.
Purpose of the Study:
- To elucidate the initial signal transduction mechanisms of GLP-2.
- To investigate GLP-2's proliferative effects on intestinal epithelial cells.
- To characterize the role of G-proteins in GLP-2 signaling.
Main Methods:
- Utilized the human Caco-2 cell line to study GLP-2 effects.
- Employed specific G-protein inhibitors: pertussis toxin and cholera toxin.
- Assessed cell proliferation rates and intracellular cyclic AMP (cAMP) levels.
Main Results:
- GLP-2 directly stimulated proliferation in Caco-2 cells.
- Pertussis and cholera toxin dose-dependently inhibited GLP-2-induced proliferation.
- Increased proliferation correlated with decreased intracellular cAMP concentrations.
Conclusions:
- GLP-2 bioactivity in Caco-2 cells involves a G-protein-linked signaling pathway.
- The findings suggest a complex signaling cascade initiated by GLP-2.
- This pathway is critical for mediating the intestinotrophic effects of GLP-2.